ProCE Banner Activity

A Focus on Screening to Improve Identification of Atrial Fibrillation

Clinical Thought

An advanced practice provider and a clinical pharmacist specialized in cardiovascular medicine give insight into which patients should be screened for atrial fibrillation and how useful home screening devices are in identifying this undiagnosed disease.

Released: May 17, 2023

Expiration: May 17, 2024

Share

Faculty

Stephanie Jalaba

Stephanie Jalaba, MMS, PA-C

Assistant Professor/ Physician Assistant
Department of PA Medicine
Michigan State University College of Osteopathic Medicine
East Lansing, Michigan

Kathleen A. Lusk

Kathleen A. Lusk, PharmD, BCPS, BCCP

Associate Professor
Vice Chair
Department of Pharmacy Practice
University of the incarnate Word Feik School of Pharmacy
San Antonio, Texas

Provided by

Provided by Clinical Care Options, LLC in partnership with Practicing Clinicians Exchange and ProCE, LLC.

ProCE Banner

Supporters

Supported by an educational grant from the Bristol Myers Squibb and Pfizer Alliance.

Bristol Myers Squibb

Pfizer Alliance

Partners

Practicing Clinicians Exchange

ProCE Banner

ProCE

ProCE Banner

Disclosure

Primary Author

Stephanie Jalaba, MMS, PA-C

Assistant Professor/ Physician Assistant
Department of PA Medicine
Michigan State University College of Osteopathic Medicine
East Lansing, Michigan

Stephanie Jalaba, MMS, PA-C: consultant/advisor/speaker: has no relevant financial relationships to disclose.

Kathleen A. Lusk, PharmD, BCPS, BCCP

Associate Professor
Vice Chair
Department of Pharmacy Practice
University of the incarnate Word Feik School of Pharmacy
San Antonio, Texas

Kathleen A. Lusk, PharmD, BCPS, BCCP: consultant/advisor/speaker: has no relevant financial relationships to disclose.